baber/WOPTO huggingface dataset:
Patent JP-3201771-B2 (JP)
IPC: H04L12/56
Filed: 1993-08-13
Granted: 2001-08-27
Abstract: PCT No. PCT/FI93/00319 Sec. 371 Date Apr. 14, 1994 Sec. 102(e) Date Apr. 14, 1994 PCT Filed Aug. 13, 1993 PCT Pub. No. WO94/05094 PCT Pub. Date Mar. 3, 1994.Packet data transfer in a digital cellular radio system including at least one common organization channel for sending pages, connection requests, and channel assignments so as to establish an actual connection on another channel. User data is transferred from the mobile stations to the base station interleaved with the connection request messages on at least one random-access-type organization channel in messages which will not result in a normal connection establishment. The mobile station sends a random-access-type packet data transfer request on the random-access-type organization channel. A timing advance corresponding to the distance between the base station and the mobile station is determined on the basis of the request received at the base station. The mobile station then utilizes the timing advance for sending data packets on the random-access-type organization channel in messages longer than the transfer request by timing the transfer of the messages with respect to the operation of the base station.
Patent JP-3163102-B2 (JP)
IPC: B65D81/107
Filed: 1990-04-27
Granted: 2001-05-08
Abstract: A container for the ink jet head cartridge comprises a plate-like member and a container proper forming a space for containing the ink jet head cartridge when bonded to the plate-like member. The container proper is provided with wall parts kept in a state not touching the ink jet head cartridge and with recesses projecting to the containing space from the wall parts so as to touch and support the ink jet head cartridge.
Patent JP-2694479-B2 (JP)
IPC: C07D493/10
Filed: 1990-03-30
Granted: 1997-12-24
Abstract: The present invention relates to a new class of compounds having a variable spectrum of activities for capsaicin-like responses, compositions thereof, processes for preparing the same, and uses thereof. Compounds of the invention are prepared by combining phorbol related diterpenses and homovanillac acid analogs via esterification at the exocyclic hydroxy group of the diterpene. Examples of these compounds include 20-homovanillyl-mezerein and 20-homovanillyl-12-deoxyphorbol-13-phenylacetate.
Patent JP-3390924-B2 (JP)
IPC: C12Q1/68
Filed: 1987-10-23
Granted: 2003-03-31
Abstract: Substantially pure DNA and plasmids containing the DNA which is comprised of sequences which encode proteins having hormone-binding and/or transcription-activating characteristics of a thyroid hormone. The invention further provides receptor proteins and modified functional forms for producing desired proteins in genetically engineered cells. One method involves inducing transcription of a gene whose transcription is activated by hormones complexed with receptors; the second is a method for engineering a cell and increasing and controlling production of a protein encoded by a gene whose transcription is activated by hormones complexed with receptor proteins.
Patent JP-2793218-B2 (JP)
IPC: G04G99/00
Filed: 1988-11-10
Granted: 1998-09-03
Abstract: PCT No. PCT/CH88/00208 Sec. 371 Date Jul. 11, 1989 Sec. 102(e) Date Jul. 11, 1989 PCT Filed Nov. 10, 1988 PCT Pub. No. WO89/04512 PCT Pub. Date May 18, 1989.A process for programming the perpetual calendar of a watch with analog time display is effected using elements incorporated in the watch. The hand of the watch and the position of the hand is used to indicate the steps of the programming. The operation of the stem places the watch in the program mode. If it is required to program three parameters, namely, the number of the year in a four year cycle, the number of the month of the year and the day of the month; and if the watch has a hand setting stem with three positions, each parameter to be programmed is allocated to a position of the stem and the parameters to be programmed are read from the second hand by allocating to the latter real steps corresponding to stopping positions and non allowable steps corresponding to non stopping positions.
Patent JP-3527244-B2 (JP)
IPC: D02G1/08
Filed: 1994-09-15
Granted: 2004-05-17
Abstract: PCT No. PCT/AU94/00544 Sec. 371 Date May 13, 1996 Sec. 102(e) Date May 13, 1996 PCT Filed Sep. 13, 1994 PCT Pub. No. WO95/08012 PCT Pub. Date Mar. 23, 1995Apparatus for twisting a travelling strand includes a rotary structure rotatable about a rotational axis X-X and a series of pulleys mounted on the structure in an array disposed about the rotational axis X-X with each pulley in the series mounted on the structure for rotation about an individual axis of pulley rotation which is generally parallel to the axis X-X and moves around that axis on rotation of the structure. An input strand guide pulley guides an input strand to be twisted onto a path in which it will successively engage the pulleys and a strand exit guide pulley guides the strand from that path into an exit path along the axis X-X. The rotary structure is driven through a drive shaft and the pulleys are rotated by gearing.
Patent JP-3133330-B2 (JP)
IPC: A61P7/08
Filed: 1992-04-17
Granted: 2001-02-05
Abstract: The present invention relates to the field of compositions of matter, disclosing compositions of matter which as aqueous solutions, may be used to perfuse a living or non-living subject in need of perfusion. The solutions according to the invention are typified by an aqueous solution comprising a polysaccharide oncotic agent, a physiologically compatible buffer, a simple hexose sugar, dissolved chloride salts of calcium, sodium and magnesium, and a dissolved organic salt of sodium. The solutions according to the invention are effective substitutes for blood. In addition the solution according to the invention may be used to preserve the biological integrity of the organs of a mammalian donor organism as shown by superior anatomical integrity of cryopreserved organs and tissues of subjects perfused with the solution of the invention. The solutions may be used for a number of purposes including maintaining a partially or substantially completely exsanguinated subject at temperatures substantially below those normally maintained by a mammal. The solutions may be used in conjunction with hyperbaric environments to maintain such partially or completed exsanguinated subjects alive without infusing blood back into the subject. Methods for using the solutions for these purposes are disclosed.
Patent JP-3907698-B2 (JP)
IPC: C12N7/00
Filed: 1995-10-02
Granted: 2007-04-18
Abstract: The present invention relates to a host cell infected using a composition of recombinant virus which has incorporated into its genome or portion thereof a gene encoding an antigen to a disease causing agent and a recombinant virus which has incorporated into its genome or portion thereof a gene encoding an immunostimulatory molecule(s) for the purpose of stimulating an immune response against the disease causing agent. Method of treatment of diseases such as cancer and diseases caused by pathogenic microorganisms is provided using the composition.
Patent JP-4342610-B2 (JP)
IPC: H01M10/0568
Filed: 1996-08-08
Granted: 2009-10-14
Abstract: A condition indicator assembly (tester) for determining the condition of a main cell, e.g. a battery, is disclosed. The condition indicator assembly may comprise an electrochemical indicator cell connected in series to a auxiliary cell. The indicator cell and auxiliary cell each have an anode, cathode and electromotive force (e.m.f.) of its own. The condition indicator assembly may be permanently connected in parallel to the terminals of a main cell being tested. The condition indicator assembly is thin enough that it may be interated into a label for the main cell. As the main cell discharges, the indicator cell anode clears proportionally to the discharge of one of the electrodes of the main cell to provide a continuous visually discernible indication of the state of charge of the main cell.
Patent JP-3315697-B2 (JP)
IPC: A61B5/363
Filed: 1993-01-28
Granted: 2002-08-19
Abstract: A closed-heart method for treating ventricular tachycardia in a myocardial infarct patient afflicted with ventricular tachycardia is disclosed. The method comprises, first, defining a thin layer of spared myocardial tissue positioned between the myocardial infarct scar tissue and the inner surface of the myocardium (the endocardium) of the patient, and then ablating the thin layer of spared myocardial tissue by a closed-heart procedure with an ablation catheter. Apparatus for carrying out the method is also disclosed, Also disclosed is a method for prognosing the likelihood of ventricular tachycardia occuring in a myocardial infarct patient not previously diagnosed as afflicted with ventricular tachycardia. The method comprises detecting a thin layer of spared myocardial tissue positioned between the myocardial infarct scar tissue and the inner surface of the myocardium (the endocardium) in the patient.
Patent JP-3016856-B2 (JP)
IPC: A47K17/02
Filed: 1990-11-06
Granted: 2000-03-06
Abstract: PCT No. PCT/NL90/00168 Sec. 371 Date Dec. 2, 1991 Sec. 102(e) Date Dec. 2, 1991 PCT Filed Nov. 6, 1990 PCT Pub. No. WO91/06238 PCT Pub. Date May 16, 1991.A handle for sanitary facilities such as toilet stalls for handicapped persons includes a middle portion with an elongated axis and two end portions which are bent at oblique angles from the axis. Each end portion is received in a projecting portion of a fastening device. The fastening device is formed of truncated cone-like bodies, one of which has screw-receiving holes which are covered by a snap-on cover.
Patent JP-2729533-B2 (JP)
IPC: C09J151/00
Filed: 1994-03-03
Granted: 1998-03-18
Abstract: PCT No. PCT/EP94/00624 Sec. 371 Date Oct. 2, 1995 Sec. 102(e) Date Oct. 2, 1995 PCT Filed Mar. 3, 1994 PCT Pub. No. WO94/20556 PCT Pub. Date Sep. 15, 1994The invention relates to core/shell copolymer dispersions whose shell comprises hydrolyzable organosilicon comonomers, the shell consisting of a copolymer comprising, a) from 70 to 95% by weight of acrylic and/or methacrylic C1 to C10 alkyl esters of which from 20 to 80% by weight, based on the overall weight of a), have a water-solubility of not more than 2 g/l and from 80 to 20% by weight, based on the overall weight of a), have a water-solubility of at least 10 g/l, b) from 5 to 25% by weight of one or more ethylenically unsaturated, functional and water-soluble monomers including a proportion of from 25 to 100% by weight, based on the overall weight of b), of unsaturated carboxylic acids, and c) from 0.01 to 10% by weight of one or more olefinically unsaturated, hydrolyzable silicon compounds of the general formula R1-Si(OR2)3, and whose core, making up a proportion of from 75 to 98% by weight of the overall weight of the core/shell copolymer, consists of a polymer comprising d) one or more comonomers from the group consisting of vinyl esters, acrylic and/or methacrylic esters, vinyl chloride, vinylaromatic compounds and ethylene.
Patent JP-3150347-B2 (JP)
IPC: H01L21/56
Filed: 1997-12-26
Granted: 2001-03-26
Abstract: When mounting an IC chip 1 on a circuit board 4, bumps 3 are formed on electrodes 2 on the IC chip, and the bumps and the electrodes of the circuit board are aligned in position with each other with interposition of an insulative thermosetting resin 6 having no conductive particle between the electrodes of the circuit board and the bumps. The IC chip is pressed against the circuit board with a pressure force of not smaller than 20 gf per bump by a heated head 8 so as to perform warp correction of the IC chip and the board, while the resin interposed between the IC chip and the circuit board is hardened to bond the IC chip and the circuit board together. <IMAGE> <IMAGE> <IMAGE> <IMAGE> <IMAGE> <IMAGE> <IMAGE> <IMAGE> <IMAGE> <IMAGE>
Patent JP-3521234-B2 (JP)
IPC: B29K105/06
Filed: 1997-04-04
Granted: 2004-04-19
Abstract: A method and apparatus are provided for forming a joint in an elongate article formed from a thermoplastic material, for example an escalator handrail or a conveyor belt, which also includes a plurality of reinforcing cables and a slider fabric. End parts of the article are held in a mold and heated to remelt the material. Portions adjacent the end parts are chilled, at ends of the mold, to prevent remelting. The molten end parts then fuse, and the molten joint is then cooled to resolidify the material and form the joint. With reinforcing cables being present, these can be cut into an interlace pattern, which advantageously is provided in just a layer of the article rather than extending through the full depth of the article. A top layer can then be replaced by a separate top cap of the material of the body of the article. Where a slider is present, to provide an effective interlacing effect, a bottom layer or portion of a handrail is cut at an inclined angle, to form an inclined joint in the slider.
Patent PL-158235-B2 (PL)
Title: Electrode for electrolytical refining of molten metals
IPC: G11B15/18
Filed: 1989-10-23
Abstract: The circuit of tape recorder power feeder, made with the use of a separate winding feeder and separate tape rewinding feeder, which are connected parallel, and in this manner, they are connected to the bridge configuration of the driving motor, characterized in that it comprises one feeder, whose stabilizing transistor (T), powered by 24 V, has the base which is connected, through a variable and fixed resistor, to the transistor's (Ta) collector, the emitter of the transistor's (Ta) collector is connected with the material of the circuit and its base is connected, via a resistor, with the read (O) lead, the lead (P) for the "PAUSE" function is connected to the diode's cathode (D), whose anode is connected to the anode of the diode activated in the read (O) lead branch.<IMAGE>
Patent AU-2000261978-B2 (AU)
Title: Human igm antibodies with the capability of inducing remyelination, and diagnostic and therapeutic uses thereof particularly in the central nervous system
Inventor: RODRIGUEZ MOSES
IPC: A61K35/12
Filed: 2000-05-30
Granted: 2006-07-06
Abstract: Methods are described for treating demyelinating diseases in mammals, such as multiple sclerosis in humans, and viral diseases of the central nervous system of humans and domestic animals, such as post-infectious encephalomyelitis, or prophylactically inhibiting the initiation or progression of demyelination in these disease states, using human monoclonal autoantibodies characterized by their ability to bind structures and cells within the central nervous system. In particular, the methods utilize human monoclonal antibodies selected from the group of sHIgM22 (LIM 22), sHIgM46 cbvHIgM MSI19D10, CB2bG8, AKJR4, CB2iE12, CB2iE7 and MSI 19E5, monomers thereof, active fragments thereof and isolated or synthetic human or humanized autoantibodies having the characteristics of the foregoing. Nucleic acids and DNA molecules encoding the human monoclonal antibodies, or portions thereof, are provided. The invention also extends to the preparation and use of human polyclonal and monoclonal autoantibodies, monomers thereof, active fragments, peptide derivatives and fragments, and analogs, cognates, agonists and the like corresponding materials, and their use in diagnostic and therapeutic applications. For example, the autoantibodies, monomers, fragments, haptens, and peptide equivalents, are useful in the promotion of neural regeneration and neuroprotection, and therapeutic compositions and vaccines containing peptides or antibodies are included and presented.
Patent AU-2001242437-B2 (AU)
Title: Method for producing a aluminium hydroxide Gel
Inventor: SCHUBERT JURGEN
IPC: C01F7/142
Filed: 2001-02-28
Granted: 2005-03-24
Abstract: The invention relates to a method for producing a stable aluminium hydroxide gel on the basis of the sodium aluminate lye which is obtained during the production of Al2O3 according to the BAYER method. The caustic mol ratio (Na2Ofree/Al2O3) of the lye containing aluminate is adjusted to smaller than 1.6. The lye is treated with carboxylic acid anhydride, whereby the aluminium hydroxide gel is precipitated at a temperature of below approximately 40° C., whereby the pH value ranges from 8 to 12. The precipitation product and the lye are separated from one another. The precipitation product is washed and dried, whereby the amorphous structure is obtained.
Patent AU-2001262157-B2 (AU)
Title: Device for cultivating plant or animal tissue cultures
Inventor: RIPPLINGER PETER
IPC: C12M1/26
Filed: 2001-04-02
Granted: 2005-07-07
Abstract: An arrangement for cultivating plant or animal tissue comprising a fermenter container, a supply for liquid nutrients and gases, a discharger for used nutritive liquids and gases, and solid carrier plates for the plant tissues, is new. An arrangement for cultivating plant or animal tissue comprising a fermenter container, a supply for liquid nutrients and gases, a discharger for used nutritive liquids and gases, and solid carrier plates for the plant tissues, where the latter are permeable to the liquid nutrients and gases, the fermenter consists of a dimensionally stable lid component that carries the supply and discharge lines as well as the carrier for the cells, and consists of a pot or bag shaped plastic hose with an opening sealed against the lid, is new.
Patent AU-2001287747-B2 (AU)
Title: Episulfide based polymerizable composition catalyzed by an (Alkoxyphenyl) phosphine
Inventor: KEITA GABRIEL
IPC: C08G75/08
Filed: 2001-09-24
Granted: 2005-11-17
Abstract: The room temperature polymerizable composition comprises at least one polymerizable monomer having at least one episulfide functionality and an effective amount of at least one (alkoxyphenyl)phosphine polymerization catalyst.
Patent AU-2002309683-B2 (AU)
Title: Fibers comprising starch and biodegradable polymers
Inventor: O'DONNELL HUGH JOSEPH
IPC: D04H1/42
Filed: 2002-05-09
Granted: 2005-07-07
Abstract: Environmentally degradable finely attenuated fibers produced by melt spinning a composition comprising destructurized starch, a biodegradable thermoplastic polymer, and a plasticizer are disclosed. The present invention is also directed to highly attenuated fibers containing thermoplastic polymer microfibrils which are formed within the starch matrix of the finely attenuated fiber. Nonwoven webs and disposable articles comprising the highly attenuated fibers are also disclosed.
Patent AU-2002363167-B2 (AU)
Title: Developer constituents and their use for dying keratin fibers
Inventor: HOFFKES HORST
IPC: D06P3/08
Filed: 2002-10-17
Granted: 2008-05-22
Abstract: Compositions for dyeing keratinic fibers, which contain p-phenylene-diamine derivative substituted by an imidazolyl group, the use of these compounds for dyeing keratinic fibers and a process for dyeing keratinic fibers using these compounds.
Patent AU-2003215553-B2 (AU)
Title: Method for producing 2-chloromethylphenyl acetic acid derivatives
Inventor: CULLMANN OLIVER
IPC: C07C249/12
Filed: 2003-02-06
Granted: 2009-05-28
Abstract: The invention relates to a method for producing 2-chloromethylphenyl acetic acid derivatives of formula (I), in which X represents C1-C4 alkoxy or methylamino, by cleaving the ether bonds in compounds of formula (II), in which R represents C1-C4 alkyl, C1-C4 alkoxy, C1-C2 alkyl halide, C1-C4 alkylcarbonyl, C1-C4 alkylcarbonyloxy, halogen, nitro or cyano, and X has the above-mentioned meaning. The inventive method is characterized in that the transformation takes place in the presence of hydrogen chloride and of an inert solvent, and in that a catalyst selected from the group comprised of: iron, indium or halogenides, oxides or triflates thereof is added to the reaction mixture.
Patent AU-2003233147-B2 (AU)
Title: Autoimmune conditions and NADPH oxidase defects
Inventor: HOLMDAHL RIKARD
IPC: G01N33/564
Filed: 2003-05-13
Granted: 2008-03-06
Abstract: The invention relates to methods and materials involved in diagnosing and treating autoimmune conditions. In particular, the invention relates to methods and materials involved in diagnosing arthritis conditions that are accompanied by an NADPH oxidase deficiency, methods and materials involved in treating, preventing, or delaying the onset of arthritis conditions that are accompanied by an NADPH oxidase deficiency, and methods and materials involved in identifying agonists and antagonists of NADPH oxidase activity.
Patent AU-2003258068-B2 (AU)
Title: Food carrier and method
Inventor: CUOMO ANGELO V
IPC: B65D71/62
Filed: 2003-08-06
Granted: 2008-09-11
Abstract: A carrier (20) comprises, in combination, a central support structure (22), at least one foldable tray (30) secured to said central support structure, said tray comprising a vertical side-wall structure (40, 42, 44) and a horizontal support structure (46) foldably secured to one of said central support structure and said vertical side-wall structure, said horizontal support panel having the size and shape to fit into said vertical side-wall structure when both said vertical side-wall structure and said horizontal support structure are unfolded so as to hold said side-wall and said carrier erect, and a holding structure (100, 88, 58) for holding said horizontal support structure relative to said side-wall structure to support a load to be carried by said carrier.
Patent AU-2004247376-B2 (AU)
Title: Uniformly coloured ceramic framework and ceramic colouring solution
Inventor: HAUPTMANN HOLGER
IPC: C04B41/50
Filed: 2004-06-09
Granted: 2009-11-12
Abstract: The present invention relates to a colouring solution for ceramic framework, the ceramic framework coloured with the solution as well as a process to obtain a uniformly coloured ceramic framework. The solution comprises a solvent, a metal salt and polyethylene glycol having a Mn in the range of 1.000 to 200.000.
Patent AU-2004296868-B2 (AU)
Title: Methods for suppressing an immune response or treating a proliferative disorder
Inventor: MOSS JOEL
IPC: A61K31/496
Filed: 2004-12-09
Granted: 2010-11-25
Abstract: Disclosed herein are methods for suppressing an immune response in a subject, treating a neoplasm in a subject, or treating a fibroproliferative vascular disease in a subject, that includes administering to the subject a therapeutically effective amount of a 2-(4-piperazinyl)-substituted 4H-1-benzopyran-4-one compound, or a pharmaceutically acceptable salt thereof, having the structure of wherein the presence of each of R1 and R2 is optional and R1 and R2 are each independently selected from alkyl, substituted alkyl, heteroalkyl, cycloalkyl, substituted cycloalkyl, heterocycloalkyl, substituted heterocycloalkyl, aryl, substituted aryl, heteroaryl, substituted heteroaryl, alkoxy, halogen, hydroxy, or amino.
Patent AU-2005233485-B2 (AU)
Title: Polymer composition
Inventor: KLEPPE EMIL ARNE
IPC: C08K5/5419
Filed: 2005-04-18
Granted: 2010-04-22
Abstract: Polymer composition comprising a) 10-99.99% by weight of at least one polyolefin, b) 0-50% by weight of a thermoplastic that is not a polyolefin, c) 0.005-1% by weight of per se known polymer additives, as well as an additional component chosen among d) at least one polybranched organic/inorganic hybrid polymer which has an inorganic core carrying organic branches, the core and branches forming a particulate structure, or/and e) a fat-soluble metal compound prepared by reacting a metal salt and an acidic, organic compound in a process in which a suitable oxidation agent ensures that all the metal in the end product is present in its highest stable oxidation state at standard conditions (25° C. and maximum 98% humidity).